“…The ICGC PCAWG study was searched for validated data on SVs, SNVs, insertion/deletions (indels), mutational signatures, and clinical data (sex, age at diagnosis, and survival time) in patients with breast (BRCA-EU, BRCA-UK), ovarian (OV-AU), pancreatic (PACA-AU, PACA-CA), gastric (GACA-CN), liver (LICA-FR, LINC-JP, LIRI-JP) and prostate (PRAD-CA, PRAD-UK) cancers, and in patients with pancreatic endocrine neoplasms (PAEN-IT, PAEN-AU) and chronic lymphocytic leukemia (CLLE-ES) 18 . Validated data on SVs and SNVs in mouse embryonic fibroblast cells (MEFs) were obtained from a previous study 17 .…”